my account log out | |
Virus-Like Particles (VLPs) for Vaccine Development |
Create: 03/26/2019 |
Expired Date: | never |
Category: | Drugs&Pharmaceutical [Health&Medical&Pharmaceutical] |
Message: | Creative Biolabs has been dedicated to leveraging extensive efforts in development of virus-like particles (VLPs)-based vaccines. During the past decades, we have established multiple leading-edge VLPs technology platforms. Focused on VLPs application with an expanding spectrum, we can guarantee our clients with the most efficient and reliable service of VLP-based vaccines development. https://www.creative-biolabs.com/virus-like-particles-vlps-for-vaccine-development.html |
City: | Shirley[US] |
Location: | |
Feb 01 2023 | VBS++ (with Ca and Mg) Buffer | 126 | |
Feb 01 2023 | GVBE Buffer | 125 | |
Feb 01 2023 | GVB++ (with Ca and Mg) Buffer | 132 | |
Feb 01 2023 | Hemolysin (Rabbit Anti-Sheep Cell Hemolysin) | 121 | |
Aug 30 2019 | Anti-HSV-2 gH Antibody | 304 | |
Aug 30 2019 | Anti-L. major LPG Antibody | 320 | |
Aug 30 2019 | Anti-DENV-1 Antibody | 290 | |
Aug 30 2019 | Anti-BPV-1 L1 Antibody | 314 | |
Aug 30 2019 | Anti-H3N2 HA Antibody | 301 | |
Aug 30 2019 | Anti-EIAV env Antibody | 317 |
Copyright © 2012-2017 toextrade Inc. All rights reserved. Contact us DeepData© |